Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical TrialStefano Rusconi, Giulia Marchetti, Emanuele Focà et al.|PLoS ONE|2013Cited by 42
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAARTStefano Rusconi, GC Marchetti, P Vitiello et al.|Journal of the International AIDS Society|2010Cited by 10